LOX and rheumatoid arthritis: The correlation of DAS28 and its improvement with the anti-inflammatory CYP-450 dihydroxy-fatty acids metabolites and the LOX derived LXA4 possibly reflects the intact innate anti-inflammatory pathways in these patients still trying to lessen the RA disease burden.